beta

SCMP

Sucampo Pharmaceuticals Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Sucampo Pharmaceuticals Inc is a pharmaceutical company having its primary market in the United States. It generates revenue from the sale of drugs for the treatment of gastrointestinal diseases.

Market Cap: 845 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.sucampo.com

Shares Outstanding: 47.2 Million

Float: 46.9 Million

Dividend: 0.0 (0.0%)

Beta: 1.344636

Sector: Healthcare

Industry: Drug Manufacturers

Ethical Flags

Longest drawdown: 694 trading days

From: 2015-09-17 To: 2018-02-13

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud